The Global Clinical Trial Industry is on the brink of a remarkable transformation, with an anticipated valuation of US$120.97 billion in 2024 and a steady climb projected at a 4.3% Compound Annual Growth Rate (CAGR) through 2034. By the end of this period, the market is forecasted to reach an impressive US$184.61 billion. The increase …